Ambulatory blood pressure measurement what is the international consensus?

Hypertension

Volumn 62, Issue 6, 2013, Pages 988-994

  O'Brien, Eoin ^a   Parati, Gianfranco ^b,c   Stergiou, George ^d  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

^d Third University   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE METER; BLOOD PRESSURE MONITORING; BLOOD PRESSURE VARIABILITY; CLINICAL PRACTICE; COMPUTER; COMPUTER PROGRAM; COST EFFECTIVENESS ANALYSIS; HEALTH CARE AVAILABILITY; HIGH RISK PATIENT; HOME MONITORING; HUMAN; HYPERTENSION; HYPOTENSION; MASKED HYPERTENSION; MEASUREMENT ACCURACY; MEDICAID; MEDICARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESISTANT HYPERTENSION; REVIEW; SLEEP DISORDERED BREATHING; SYSTEMATIC REVIEW (TOPIC); WAKEFULNESS; WHITE COAT HYPERTENSION; BLOOD PRESSURE; CONSENSUS; PATHOPHYSIOLOGY; PHYSIOLOGY;

BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CONSENSUS; HUMANS; HYPERTENSION;

EID: 84891591669     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.113.02148     Document Type: Review

References (40)

1. O'Brien E, Asmar R, Beilin L, et al; European Society of Hypertension Working Group on Blood Pressure Monitoring. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens. 2003;21:821-848.
2. Parati G, Stergiou GS, Asmar R, et al; ESH Working Group on Blood Pressure Monitoring. European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring. J Hypertens. 2008;26:1505-1526.
3. CMS.gov. Centers for Medicare & Medicaid Services. Medicare coverage policy decisions. ABPM monitoring (#CAG-00067N). 2001. http://www.cms.gov/ medicare-coverage-database/details/nca-decision-memo.aspx?N CAId=5&NcaName= Ambulatory+Blood+Pressure+Monitoring&ver=9 &from= %252527lmrpstate%252527&contractor=22&name=CIGNA+G overnment+Services+ (05535) +-+Carrier&letter-range=4&bc=gCAAAA AAIAAA&. Assessed August 20, 2013.
4. National Institute for Health and Clinical Excellence (NICE). Hypertension: the clinical management of primary hypertension in adults. Clinical Guideline 127. 2011. www.nice.org.uk/guidance/CG127. Assessed August 20, 2013.
5. Clement DL, ed. Blood pressure variability: proceedings of the International Workshop on Blood Pressure Variability held at the University Hospital, Ghent; June 15-16, 1978; UK: MTP Press Ltd.
6. O'Brien E, Parati G, Stergiou G, et al; the European Society of Hypertension Working Group on Blood Pressure Monitoring. European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens. 2013;31:1731-1767.
7. O'Brien E, Atkins N, Stergiou G, Karpettas N, Parati G, Asmar R, Imai Y, Wang J, Mengden T, Shennan A; Working Group on Blood Pressure Monitoring of the European Society of Hypertension. European Society of Hypertension International Protocol revision 2010 for the validation of blood pressure measuring devices in adults. Blood Press Monit. 2010;15:23-38.
8. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206-1252.
9. Mancia G, Fagard R, Narkiewicz K, et al; List of authors Task Force Members. 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31:1281-1357.
10. Kikuya M, Hansen TW, Thijs L, Björklund-Bodegård K, Kuznetsova T, Ohkubo T, Richart T, Torp-Pedersen C, Lind L, Ibsen H, Imai Y, Staessen JA; International Database on Ambulatory blood pressure monitoring in relation to Cardiovascular Outcomes Investigators. Diagnostic thresholds for ambulatory blood pressure monitoring based on 10-year cardiovascular risk. Circulation. 2007;115:2145-2152.
11. Ohkubo T, Imai Y, Tsuji I, Nagai K, Ito S, Satoh H, Hisamichi S. Reference values for 24-hour ambulatory blood pressure monitoring based on a prognostic criterion: the Ohasama Study. Hypertension. 1998;32:255-259.
12. Fagard RH, Staessen JA, Thijs L. Optimal definition of daytime and nighttime blood pressure. Blood Press Monit. 1997;2:315-321.
13. *: ambulatory blood pressure measurement is essential for the management of hypertension. J Clin Hypertens (Greenwich). 2012;14:836-847.
14. Pickering TG, James GD, Boddie C, Harshfield GA, Blank S, Laragh JH. How common is white coat hypertension? JAMA. 1988;259:225-228.
15. Myers MG, Reeves RA. White coat phenomenon in patients receiving antihypertensive therapy. Am J Hypertens. 1991;4(10 pt 1):844-849.
16. Parati G, Ulian L, Santucciu C, Omboni S, Mancia G. Difference between clinic and daytime blood pressure is not a measure of the white coat effect. Hypertension. 1998;31:1185-1189.
17. Owens P, Atkins N, O'Brien E. Diagnosis of white coat hypertension by ambulatory blood pressure monitoring. Hypertension. 1999;34:267-272.
18. Pickering TG, Davidson K, Gerin W, Schwartz JE. Masked hypertension. Hypertension. 2002;40:795-796.
19. Metoki H, Ohkubo T, Kikuya M, Asayama K, Obara T, Hashimoto J, Totsune K, Hoshi H, Satoh H, Imai Y. Prognostic significance for stroke of a morning pressor surge and a nocturnal blood pressure decline: the Ohasama study. Hypertension. 2006;47:149-154.
20. Dolan E, Stanton A, Thijs L, Hinedi K, Atkins N, McClory S, Den Hond E, McCormack P, Staessen JA, O'Brien E. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension. 2005;46:156-161.
21. Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M, Matsubara M, Hashimoto J, Hoshi H, Araki T, Tsuji I, Satoh H, Hisamichi S, Imai Y. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J Hypertens. 2002;20:2183-2189.
22. Fan HQ, Li Y, Thijs L, et al; International Database on Ambulatory Blood Pressure In Relation to Cardiovascular Outcomes Investigators. Prognostic value of isolated nocturnal hypertension on ambulatory measurement in 8711 individuals from 10 populations. J Hypertens. 2010;28:2036-2045.
23. American Diabetes Association. Standards of medical care in diabetes-2013. Diabetes Care. 2013;36(suppl 1):S11-S66.
24. Agarwal R, Bills JE, Hecht TJ, Light R P. Role of home blood pressure monitoring in overcoming therapeutic inertia and improving hypertension control: a systematic review and meta-analysis. Hypertension. 2011;57:29-38.
25. Sega R, Facchetti R, Bombelli M, Cesana G, Corrao G, Grassi G, Mancia G. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation. 2005;111:1777-1783.
26. Parati G, Omboni S, Bilo G. Why is out-of-office blood pressure measurement needed? Home blood pressure measurements will increasingly replace ambulatory blood pressure monitoring in the diagnosis and management of hypertension. Hypertension. 2009;54:181-187.
27. Parati G, Ochoa JE, Lombardi C, Bilo G. Assessment and management of blood pressure variability. Nat Rev Cardiol. 2013;10;143-155.
28. Rothwell PM, Howard SC, Dolan E, O'Brien E, Dobson JE, Dahlöf B, Sever PS, Poulter NR. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet. 2010;375:895-905.
29. Mancia G, Bombelli M, Facchetti R, Madotto F, Corrao G, Trevano FQ, Grassi G, Sega R. Long-term prognostic value of blood pressure variability in the general population: results of the Pressioni Arteriose Monitorate e Loro Associazioni Study. Hypertension. 2007;49:1265-1270.
30. Kikuya M, Ohkubo T, Metoki H, Asayama K, Hara A, Obara T, Inoue R, Hoshi H, Hashimoto J, Totsune K, Satoh H, Imai Y. Day-by-day variability of blood pressure and heart rate at home as a novel predictor of prognosis: the Ohasama study. Hypertension. 2008;52:1045-1050.
31. Rothwell PM, Howard SC, Dolan E, O'Brien E, Dobson JE, Dahlöf B, Poulter NR, Sever PS; ASCOT-BPLA and MRC Trial Investigators. Effects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke. Lancet Neurol. 2010;9:469-480.
32. Hansen TW, Thijs L, Li Y, et al; International Database on Ambulatory Blood Pressure in Relation to Cardiovascular Outcomes Investigators. Prognostic value of reading-to-reading blood pressure variability over 24 hours in 8938 subjects from 11 populations. Hypertension. 2010;55:1049-1057.
33. O'Brien E. Twenty-four-hour ambulatory blood pressure measurement in clinical practice and research: a critical review of a technique in need of implementation. J Intern Med. 2011;269:478-495.
34. Krakoff LR. Cost-effectiveness of ambulatory blood pressure: a reanalysis. Hypertension. 2006;47:29-34.
35. White WB. Expanding the use of ambulatory blood pressure monitoring for the diagnosis and management of patients with hypertension. Hypertension. 2006;47:14-15.
36. Lovibond K, Jowett S, Barton P, Caulfield M, Heneghan C, Hobbs FD, Hodgkinson J, Mant J, Martin U, Williams B, Wonderling D, McManus RJ. Cost-effectiveness of options for the diagnosis of high blood pressure in primary care: a modelling study. Lancet. 2011;378:1219-1230.
37. Zanchetti A, Mancia G. Longing for clinical excellence: a critical outlook into the NICE recommendations on hypertension management-is nice always good? J Hypertens. 2012;30:660-668.
38. Tamaki Y, Ohkubo T, Kobayashi M, Sato K, Kikuya M, Obara T, Metoki H, Asayama K, Hirose T, Totsune K, Suzuki K, Imai Y. Cost effectiveness of hypertension treatment based on the measurement of ambulatory blood pressure. Yakugaku Zasshi. 2010;130:805-820.
39. Green BB, Cook AJ, Ralston JD, Fishman PA, Catz SL, Carlson J, Carrell D, Tyll L, Larson EB, Thompson RS. Effectiveness of home blood pressure monitoring, Web communication, and pharmacist care on hypertension control: a randomized controlled trial. JAMA. 2008;299:2857-2867.
40. James K, Salvi L, Leahy A, Dolan E, O'Brien E. The profile of patients having ambulatory blood pressure monitoring in a pharmacy setting. J Hypertens. 2013;31:e-Supplement A. 22.